161 related articles for article (PubMed ID: 16061284)
1. Expression of natural cytotoxicity receptors NKp30, NKp44, and NKp46 mRNAs and proteins by human hematopoietic and non-hematopoietic cells.
Srivastava BI; Srivastava MD
Leuk Res; 2006 Jan; 30(1):37-46. PubMed ID: 16061284
[TBL] [Abstract][Full Text] [Related]
2. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44).
De Maria A; Fogli M; Costa P; Murdaca G; Puppo F; Mavilio D; Moretta A; Moretta L
Eur J Immunol; 2003 Sep; 33(9):2410-8. PubMed ID: 12938217
[TBL] [Abstract][Full Text] [Related]
3. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
von Lilienfeld-Toal M; Nattermann J; Feldmann G; Sievers E; Frank S; Strehl J; Schmidt-Wolf IG
Clin Exp Immunol; 2006 Jun; 144(3):528-33. PubMed ID: 16734623
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).
Mavoungou E; Bouyou-Akotet MK; Kremsner PG
Clin Exp Immunol; 2005 Feb; 139(2):287-96. PubMed ID: 15654827
[TBL] [Abstract][Full Text] [Related]
5. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
Marcenaro E; Augugliaro R; Falco M; Castriconi R; Parolini S; Sivori S; Romeo E; Millo R; Moretta L; Bottino C; Moretta A
Eur J Immunol; 2003 Dec; 33(12):3367-76. PubMed ID: 14635045
[TBL] [Abstract][Full Text] [Related]
6. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.
Walzer T; Bléry M; Chaix J; Fuseri N; Chasson L; Robbins SH; Jaeger S; André P; Gauthier L; Daniel L; Chemin K; Morel Y; Dalod M; Imbert J; Pierres M; Moretta A; Romagné F; Vivier E
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3384-9. PubMed ID: 17360655
[TBL] [Abstract][Full Text] [Related]
7. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.
Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q
Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431
[TBL] [Abstract][Full Text] [Related]
8. Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression.
Kim HR; Chwae YJ; Kim J
Scand J Immunol; 2010 Jun; 71(6):413-9. PubMed ID: 20500693
[TBL] [Abstract][Full Text] [Related]
9. NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
Fuller CL; Ruthel G; Warfield KL; Swenson DL; Bosio CM; Aman MJ; Bavari S
Cell Microbiol; 2007 Apr; 9(4):962-76. PubMed ID: 17381429
[TBL] [Abstract][Full Text] [Related]
10. NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli.
Hollyoake M; Campbell RD; Aguado B
Mol Biol Evol; 2005 Aug; 22(8):1661-72. PubMed ID: 15872155
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT
Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895
[TBL] [Abstract][Full Text] [Related]
12. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.
Hecht ML; Rosental B; Horlacher T; Hershkovitz O; De Paz JL; Noti C; Schauer S; Porgador A; Seeberger PH
J Proteome Res; 2009 Feb; 8(2):712-20. PubMed ID: 19196184
[TBL] [Abstract][Full Text] [Related]
13. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
Nattermann J; Feldmann G; Ahlenstiel G; Langhans B; Sauerbruch T; Spengler U
Gut; 2006 Jun; 55(6):869-77. PubMed ID: 16322112
[TBL] [Abstract][Full Text] [Related]
14. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
[TBL] [Abstract][Full Text] [Related]
15. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
Romero AI; Thorén FB; Brune M; Hellstrand K
Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024
[TBL] [Abstract][Full Text] [Related]
16. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
[TBL] [Abstract][Full Text] [Related]
17. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells.
Vacca P; Cantoni C; Prato C; Fulcheri E; Moretta A; Moretta L; Mingari MC
Int Immunol; 2008 Nov; 20(11):1395-405. PubMed ID: 18815119
[TBL] [Abstract][Full Text] [Related]
18. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
[TBL] [Abstract][Full Text] [Related]
19. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
20. Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients.
Fogli M; Costa P; Murdaca G; Setti M; Mingari MC; Moretta L; Moretta A; De Maria A
Eur J Immunol; 2004 Aug; 34(8):2313-21. PubMed ID: 15259029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
